Oxlumo 94.5 mg/0.5 mL solution for injection

*
Pharmacy Only: Prescription
  • Company:

    Alnylam UK Ltd.
  • Status:

    No Recent Update
  • Legal Category:

    Product subject to restricted prescription (C)
  • Active Ingredient(s):

    This medicinal product is subject to additional monitoring.

    *Additional information is available within the SPC or upon request to the company

Updated on 13 June 2023

File name

Oxlumo SmPC -IE.pdf

Reasons for updating

  • New SPC for new product

Legal category:Product subject to restricted prescription (C)

Free text change information supplied by the pharmaceutical company

Updated following carcinogenicity

Updated on 13 June 2023

File name

Oxlumo SmPC -IE.pdf

Reasons for updating

  • New SPC for new product

Legal category:Product subject to restricted prescription (C)

Updated on 13 June 2023

File name

Oxlumo SmPC -IE.pdf

Reasons for updating

  • New SPC for new product

Legal category:Product subject to restricted prescription (C)

Updated on 19 January 2023

File name

SmPC-IE-Oxlumo.pdf

Reasons for updating

  • Document format updated

Legal category:Product subject to restricted prescription (C)

Updated on 16 December 2021

File name

2021-12-16-Oxlumo EU SmPC Mouse Study IE.pdf

Reasons for updating

  • Change to section 5.3 - Preclinical safety data

Legal category:Product subject to restricted prescription (C)

Updated on 02 November 2021

File name

pil luma.pdf

Reasons for updating

  • New PIL for new product

Updated on 01 November 2021

File name

spc luma.pdf

Reasons for updating

  • New SPC for new product

Legal category:Product subject to restricted prescription (C)